相关实验视频

Updated: Jun 8, 2025

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

儿童神经母细胞瘤的定量核磁共振:超越对图像定义风险因素的评估

Haoru Wang¹, Jinhua Cai¹

¹From the Department of Radiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, No. 136 Zhongshan Road 2, Yuzhong District, Chongqing 400014, China.

Radiology. Imaging cancer

|November 1, 2024

概括

定量MRI为儿童神经母细胞瘤提供了先进的见解,超越了结构成像. 这些技术为更好的儿科神经母细胞瘤管理提供了非侵入性生物标志物.

科学领域:

儿科放射学儿科放射学
医学成像医学成像
在瘤学瘤学.

背景情况:

神经母细胞瘤是一种常见的儿童癌症.
磁共振成像 (MRI) 对于评估神经母细胞瘤,指导治疗和手术决策至关重要.
目前的MRI方法主要提供结构信息,限制了全面的生物评估.

研究的目的:

审查量化MRI在评估儿科神经母细胞瘤中的不断发展的应用.
突出定量MRI如何提供超越传统结构成像的非侵入性生物标志物.
讨论定量MRI在改善神经母细胞瘤管理方面的潜力.

主要方法:

关于用于神经母细胞瘤的定量MRI技术的当前文献的综述.
讨论各种定量MRI方法及其在评估图像定义风险因素中的作用.
探索定量MRI如何反映神经母细胞瘤的生物特征.

主要成果:

定量MRI增强了对神经母细胞瘤中图像定义的风险因素的评估.
新兴的定量MRI技术为神经母细胞瘤的生物特征提供了非侵入性的洞察力.
这些先进的MRI技术有望产生新的成像生物标志物.

结论:

定量核磁共振表示比神经母细胞瘤的传统解剖成像显著进步.
这些技术有望对儿科神经母细胞瘤进行更全面,非侵入性评估.
定量MRI准备在未来儿童神经母细胞瘤的治疗中发挥至关重要的作用.

关键词:

孩子孩子孩子孩子这就是为什么MRI是MRI.功能成像 MR功能成像神经母细胞瘤是一种神经母细胞瘤.儿科儿科儿科定量成像技术定量成像技术

更多相关视频

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...